Immucell (ICCC) Gross Profit (2010 - 2026)
Immucell (ICCC) reported Gross Profit of $2.44 million for Q2 2026, down 13.5% from $2.82 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Gross Profit (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immucell's Gross Profit came in at $10.53 million, down 0.6% year-over-year; for FY2025, it came in at $11.45 million, up 44.1% from FY2024.
- Gross Profit has a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- By year, Gross Profit came in at $7.94 million in FY2024 (+105.2%), $3.87 million in FY2023 (-49.4%), $7.65 million in FY2022 (-11.6%) and $8.66 million in FY2021 (+26.1%).
- Five-year quarterly Gross Profit spans a low of $300,775 in Q1 2023 and a high of $3.35 million in Q1 2025.
- Year over year, Gross Profit gained in five of the last six quarters, with growth averaging 39.8%.
- The high point for year-over-year Gross Profit in five years was Q1 2024 (growth of 663.1%); the low point was Q1 2023 (a decline of 90.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.91 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 300,775.00 |
| Dec 31, 2022 | 992,176.00 |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 2.42 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 1.60 Mn |
API Access
Immucell Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();